Glenn Wagner is a senior behavioral scientist at the RAND Corporation and a professor at the Pardee RAND Graduate School. He has been involved in clinical and behavioral HIV research for more than 20 years and has extensive experience with both HIV prevention and treatment research. For more than 10 years, Wagner has conducted several National Institutes of Health–funded research in the United States on HIV antiretroviral adherence, including methodological studies of adherence measurement and randomized, controlled studies of adherence interventions. Most recently, Wagner has led a group of RAND scientists in developing international HIV research in sub-Saharan Africa, Latin America, and the Middle East. In Uganda, his projects include a longitudinal evaluation of the social, economic, and risk behavior outcomes of HIV antiretroviral therapy (ART), evaluation of depression treatment as a moderator of ART impact, and a formative and process evaluation of microfinance programs targeting HIV clients. Future research studies based in sub-Saharan Africa will focus on fertility rights of HIV clients and improving reproductive health services. In Honduras, Wagner is working with Homero Martinez on evaluating nutritional interventions and their effects on HIV adherence and clinical outcomes. Finally, in Lebanon and Palestine, Wagner is working with colleagues at RAND to develop proposals regarding HIV prevention and risk reduction among men who have sex with men and among youth, respectively. Wagner received his Ph.D. in clinical psychology from St. John's University.
- HIV care and mental health and quality-of-life interventions for those with serious medical illness
- Effects of depression and its treatment on the impact of antiretroviral therapy on health outcomes
Remien, R. H., et al., "Couple-Focused Support to Improve HIV Medication Adherence: A Randomized Controlled Trial," AIDS, 19(8), 2005
Wagner, G. J., and G. W. Ryan, "Hepatitis C Virus Treatment Decision-Making in the Context of HIV Co-Infection: The Role of Medical, Behavioral and Mental Health Factors in Assessing Treatment Readiness," AIDS, 19, 2005
Wagner, G. J., et al., "Correlates of HIV Antiretroviral Adherence in Patients with Serious Mental Illness," AIDS Care, 16(4), 2004
Wagner, G. J., and G. W. Ryan, "Relationship Between Routinization of Daily Behaviors and Medication Adherence in HIV-Positive Drug Users," AIDS Patient Care and STDs, 18(7), 2004
Wagner, G. J., "Placebo Practice Trials: The Best Predictor of Adherence Readiness for HAART Among Drug Users?" HIV Clinical Trials, 4(4), 2003